- Home
- NVMI vs ELAN Comparison
NVMI vs ELAN Comparison
Compare NVMI & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVMI | ELAN |
|---|---|---|
| Founded | 1993 | 1954 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 10.3B |
| IPO Year | 2000 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NVMI | ELAN |
|---|---|---|
| Price | $343.75 | $22.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $320.83 | $23.11 |
| AVG Volume (30 Days) | 268.1K | ★ 5.9M |
| Earning Date | 02-12-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.31 | N/A |
| EPS | ★ 7.71 | 0.07 |
| Revenue | $852,719,000.00 | ★ $4,591,000,000.00 |
| Revenue This Year | $33.34 | $7.25 |
| Revenue Next Year | $10.21 | $5.73 |
| P/E Ratio | ★ $42.59 | $319.59 |
| Revenue Growth | ★ 39.37 | 3.08 |
| 52 Week Low | $154.00 | $8.02 |
| 52 Week High | $361.32 | $23.70 |
Technical Indicators
Market Signals| Indicator | NVMI | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 58.74 | 57.20 |
| Support Level | $328.39 | $21.95 |
| Resistance Level | $338.35 | $23.06 |
| Average True Range (ATR) | 10.29 | 0.46 |
| MACD | 1.15 | 0.07 |
| Stochastic Oscillator | 91.92 | 79.71 |
Price Performance
Historical ComparisonAbout NVMI Nova Ltd.
Nova Ltd is a semiconductor equipment manufacturer. The company provides metrology solutions for process control used in semiconductor manufacturing. The company offers in-line optical and x-ray stand-alone metrology systems, as well as integrated optical metrology systems. The product range consists of Nova 2040, Nova 3090Next, Nova i500 and i500 Plus, Nova T500, Nova T600, Nova V2600, HelioSense 100, Nova Hybrid Metrology solution, NovaMars. The company generates the majority of its revenue from China. Geographically the company has its business spread across the region of Taiwan, Korea, China, the United States, and Europe.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.